表紙:チューブレスインスリンポンプの世界市場:最終用途別の市場規模、産業分析、地域別の展望、用途別の将来性、競合市場シェア、将来予測 (2022年~2030年)
市場調査レポート
商品コード
1081232

チューブレスインスリンポンプの世界市場:最終用途別の市場規模、産業分析、地域別の展望、用途別の将来性、競合市場シェア、将来予測 (2022年~2030年)

Tubeless Insulin Pump Market Size By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 100 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
チューブレスインスリンポンプの世界市場:最終用途別の市場規模、産業分析、地域別の展望、用途別の将来性、競合市場シェア、将来予測 (2022年~2030年)
出版日: 2022年05月11日
発行: Global Market Insights Inc.
ページ情報: 英文 100 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のチューブレスインスリンポンプの市場規模は、世界中で糖尿病患者が増加していることから、2030年までに大きく成長すると予測されています。

また、糖尿病関連の医療費の増大が、今後の市場の成長をさらに促進すると予測されます。

エンドユーザー別に見ると、在宅医療分野が2021年には76%以上の収益シェアを押さえています。

当レポートでは、世界のチューブレスインスリンポンプの市場について分析し、業界の基本構造や求心力、技術・規制環境、主な市場促進・抑制要因、最終用途別・地域別の市場動向見通し、主要企業のプロファイル・業績・戦略などを調査しております。

目次

第1章 分析手法

第2章 エグゼクティブサマリー

第3章 チューブレスインスリンポンプ産業の考察

  • 産業区分
  • 産業情勢(単位:100万米ドル、2017年~2030年)
  • 業界への影響要因
    • 成長促進要因
    • 業界の潜在的リスクと課題
  • 成長可能性の分析
  • 新型コロナウイルス感染症 (COVID-19) の影響分析
  • 規制状況
  • ポーターのファイブフォース分析
  • 競合情勢 (2021年)
    • 企業のマトリックス分析 (2021年)
  • PESTEL分析

第4章 チューブレスインスリンポンプ市場:最終用途別

  • 主要セグメントの動向
  • 在宅医療
    • 市場規模:地域別 (単位:100万米ドル、2017年~2030年)
  • 病院・クリニック
  • その他

第5章 チューブレスインスリンポンプ市場:地域別

  • 地域別の主な動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
  • アジア太平洋
    • 中国
    • 日本
    • 韓国
    • オーストラリア
  • その他の地域

第6章 企業プロファイル

  • 競合ダッシュボード (2021年)
  • Insulet Corporation
  • Roche
  • Medtrum Technologies
  • Terumo Corporation
  • Zealand Pharma
  • MicroTech Medical Inc.
図表

Data Tables

  • TABLE 1. Tubeless insulin pump industry 360 degree synopsis, 2017 - 2030
  • TABLE 2. Global tubeless insulin pump market, 2017 - 2021 (USD Million)
  • TABLE 3. Global tubeless insulin pump market, 2022 - 2030 (USD Million)
  • TABLE 4. Global tubeless insulin pump market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 5. Global tubeless insulin pump market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 6. Global tubeless insulin pump market, by region, 2017 - 2021 (USD Million)
  • TABLE 7. Global tubeless insulin pump market, by region, 2022 - 2030 (USD Million)
  • TABLE 8. Industry impact forces
  • TABLE 9. Home care market size, by region, 2017 - 2021 (USD Million)
  • TABLE 10. Home care market size, by region, 2022 - 2030 (USD Million)
  • TABLE 11. Hospitals & clinics market size, by region, 2017 - 2021 (USD Million)
  • TABLE 12. Hospitals & clinics market size, by region, 2022 - 2030 (USD Million)
  • TABLE 13. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 14. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 15. North America tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 16. North America tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 17. North America tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 18. North America tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 19. U.S. tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 20. U.S. tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 21. Canada tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 22. Canada tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 23. Europe tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 24. Europe tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 25. Europe tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 26. Europe tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 27. Germany tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 28. Germany tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 29. UK tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 30. UK tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 31. France tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 32. France tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 33. Spain tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 34. Spain tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 35. Italy tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 36. Italy tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 37. Asia Pacific tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 38. Asia Pacific tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 39. Asia Pacific tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 40. China tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 41. China tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 42. Japan tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 43. Japan tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 44. South Korea tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 45. South Korea tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 46. Australia tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 47. Australia tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 48. RoW tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 49. RoW tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 50. RoW tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 51. RoW tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Data Validation
  • FIG. 3 Global tubeless insulin pump 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global tubeless insulin pump market size, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 Competitive matrix analysis, 2021
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by end-use
  • FIG. 11 Key regional trends
  • FIG. 12 Competitive dashboard, 2021
目次
Product Code: 2032

The tubeless insulin pump market is estimated to grow massively by 2030 owing to growing occurrences of diabetes around the world. In addition, escalating healthcare expenses associated with diabetes are projected to further propel market growth through the forecast timespan.

The tubeless insulin pump is an effective way to control diabetes through a Bluetooth-connected insulin management system that eliminates the need for daily insulin injections. Recent technological advances have improved pump systems by connecting tubeless insulin pumps to smartphone-type devices, which has fostered product outlook.

After the coronavirus outbreak, the burgeoning cost of insulin pumps due to worldwide supply chain disruptions impeded tubeless insulin pump market growth in the initial stages of the pandemic. However, collaborative efforts between private and public organizations have helped the market regain its pre-COVID momentum. For instance, in May 2021, Roche Diabetes Care, an innovative diabetes technologies services company, launched the mySugr Pump Control system embedded in the mySugr app to improve insulin pump therapy through smartphones.

To cite another instance, in January 2022, Insulet, a leading specialist in tubeless insulin pumps, received U.S. FDA approval for OmniPod 5, its tubeless automated insulin delivery (AID) system that can control daily insulin dosage according to the blood sugar level, in individuals over the age of six diagnosed with type 1 diabetes. The patch-like device can be easily controlled through a smartphone via the Dexcom G6 CGM (continuous glucose monitoring) system. Earlier, in July 2021, the OmniPod 5 AID system had reported successful results in a pivotal trial to reduce HbA 1c levels in children and adults with type 1 diabetes.

In another instance, in November 2021, Terumo Corporation, a medical device corporation, joined hands with a European company to enable MEDISAFE WITH, an insulin patch pump, that can be controlled by smartphone-type devices. The partnership was intended to help Terumo to enhance the operability of MEDISAFE WITH as well as normalize insulin pump therapy in the daily lives of patients.

The tubeless insulin pump market has been bifurcated based on end-use and region. In terms of end-use, the market has been further divided into hospitals & clinics, homecare, and others. The homecare segment dominated the market with more than 76% revenue share in 2021 as a result of technological advancements, growing product adoption, and soaring user preference.

In the regional landscape, apart from North America, Asia Pacific, and Europe, the RoW tubeless insulin pump market is projected to witness notable growth to be valued at around $50 million by 2030 due to the high prevalence of diabetes as well as mounting product uptake across various countries in the region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Tubeless insulin pump industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 End-use trends
    • 2.1.3 Regional trends

Chapter 3 Tubeless Insulin Pump Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of diabetes
      • 3.3.1.2 Technological advancements in tubeless insulin pump
      • 3.3.1.3 Increasing diabetes care expenditure
      • 3.3.1.4 Injuries caused by conventional & invasive insulin pumps
      • 3.3.1.5 Adoption of facilitative initiatives
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High long-term costs associated with tubeless insulin pump
      • 3.3.2.2 Stringent government regulations
  • 3.4 Growth potential analysis
    • 3.4.1 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Company matrix analysis, 2021
  • 3.9 PESTEL analysis

Chapter 4 Tubeless Insulin Pump Market, By End-use

  • 4.1 Key segment trends
  • 4.2 Home care
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Hospitals & clinics
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Others
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Tubeless Insulin Pump Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.2.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.3.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.5 Italy
      • 5.3.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.6 France
      • 5.3.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.7 Spain
      • 5.3.7.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.4 Japan
      • 5.4.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.5 South Korea
      • 5.4.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.6 Australia
      • 5.4.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.5 RoW
    • 5.5.1 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 6 Company Profiles

  • 6.1 Competitive dashboard, 2021
  • 6.2 Insulet Corporation
    • 6.2.1 Business overview
    • 6.2.2 Financial data
    • 6.2.3 Product landscape
    • 6.2.4 Strategic outlook
    • 6.2.5 SWOT analysis
  • 6.3 Roche
    • 6.3.1 Business overview
    • 6.3.2 Financial data
    • 6.3.3 Product landscape
    • 6.3.4 Strategic outlook
    • 6.3.5 SWOT analysis
  • 6.4 Medtrum Technologies
    • 6.4.1 Business overview
    • 6.4.2 Financial data
    • 6.4.3 Product landscape
    • 6.4.4 Strategic outlook
    • 6.4.5 SWOT analysis
  • 6.5 Terumo Corporation
    • 6.5.1 Business overview
    • 6.5.2 Financial data
    • 6.5.3 Product landscape
    • 6.5.4 Strategic outlook
    • 6.5.5 SWOT analysis
  • 6.6 Zealand Pharma
    • 6.6.1 Business overview
    • 6.6.2 Financial data
    • 6.6.3 Product landscape
    • 6.6.4 Strategic outlook
    • 6.6.5 SWOT analysis
  • 6.7 MicroTech Medical Inc.
    • 6.7.1 Business overview
    • 6.7.2 Financial data
    • 6.7.3 Product landscape
    • 6.7.4 Strategic outlook
    • 6.7.5 SWOT analysis